Question 1 of 3 in Business
Started Apr 09, 2019 05:47PM UTC   •   Closing Jun 26, 2019 10:00PM UTC

Will AbbVie's new psoriasis drug Skyrizi (approved in Japan) receive U.S. Food and Drug Administration approval by 30 June 2019?

Tags
Challenges

Crowd forecast over time